Promoter Aarsh S. Shah sold 35,000 shares of Sakar Healthcare Limited for ₹3.46 Cr at ₹989.49 apiece in the open market, reducing their stake from 5.78% to 5.62%.
A pharmaceutical manufacturer engaged in research and development of medicinal products, Sakar Healthcare operates across drug formulation and production for various therapeutic applications. Incorporated in 2004, the company focuses on developing and manufacturing high-quality pharmaceutical formulations. The company distinguishes itself through its commitment to research-driven product development, stringent quality control processes, and its position as a significant player in India's pharmaceutical manufacturing sector.
Get the next move the moment it happens.
Follow the investors and Sakar Healthcare Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
